The NIC is a unique partnership whose members are committed to working together to support a system where patients have faster and more consistent access to NICE-recommended medicines, treatments and technologies. This independent partnership between the NHS, the life sciences industry, healthcare professional bodies, key health organisations and the public is transformational and heralds a collaborative approach that will be critical in achieving improved outcomes for the whole population.

The signing of the NIC concordat by all its partners is the very first time that the NHS and its stakeholders have come together to work in this way and completely re-draws the landscape.

Download a copy of NICE Implementation Collaborative – Concordat.

Pilot projects

The NIC is currently engaged in four pilots that will help partners better understand the barriers to implementation of NICE recommendations. These are:

• Pilot 1 – Denosumab for post-menopausal women with osteoporosis (NICE TA204)
• Pilot 2 – Novel Oral Anti-coagulants for prevention of stroke in patients with atrial fibrillation (NICE TA 249 &256)
• Pilot 3 – Insulin pumps in type I diabetes mellitus (TA151)
• Pilot 4 – Natriuretic peptide testing in heart failure (CG108)